TP53 and hematologic disorder: Recently, many of epidemiological studies have examined the association between p53 Arg72Pro polymorphism and hematological malignancies risk, however, these studies revealed an inconsistent conclusion, probably due to the relatively small size [11], [15], [16], [17].